Table 3 Effect of A. australis venom on biochemical and antioxidant parameters of EAC-bearing mice
From: Antitumor efficacy of the Egyptian Scorpion Venom Androctonus Australis: in vitro and in vivo study
Parameter treatment | Urea (mg/dL) | Creatinine (mg/dL) | Glucose (mg/dL) | Cholesterol (mg/dL) | CAT (U/g tissue) | SOD (U/g tissue) | GSH (mg/g tissue) |
|---|---|---|---|---|---|---|---|
Normal control | 29.60 ± 1.06 | 0.10 ± 0 | 141.00 ± 2.16 | 74.20 ± 1.30 | 0.8 ± 0.03 | 149.76 ± 2.44 | 0.36 ± 0.04 |
EAC control | 84.90* ± 3.78 | 0.27* ± 0.03 | 238.67* ± 3.76 | 81.27* ± 2.79 | 0.74 ± 0.02 | 130.5 ± 2.82 | 0.32 ± 0.01 |
EAC + 1/10 LD50 (0.025 mg/kg BW) | 48.55# ± 3.78 | 0.26 ± 0.03 | 221.05# ± 4.68 | 73.82# ± 2.12 | 0.82 ± 0.02 | 165.766 ± 4.64 | 0.38 ± 0.05 |
EAC + cisplatin (2 mg/Kg BW) | 30.68# ± 2.93 | 0.23 ± 0.02 | 256.30 ± 3.45 | 76.58 ± 2.97 | 0.8 ± 0.07 | 473.04## ± 4.9 | 0.38 ± 0.02 |